Cargando…

Multimodality locoregional treatment strategies for bridging HCC patients before liver transplantation

BACKGROUND: It is current practice that patients with hepatocellular carcinoma (HCC) listed for liver transplantation should receive locoregional treatment if the suspected waiting time for transplantation is longer than 6 months, even in the absence of prospective randomized data. Aim of this study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Györi, Georg P., Felsenreich, D. Moritz, Silberhumer, Gerd R., Soliman, Thomas, Berlakovich, Gabriela A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Vienna 2017
Materias:	Original Scientific Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5653748/ https://www.ncbi.nlm.nih.gov/pubmed/29104589 http://dx.doi.org/10.1007/s10353-017-0487-8

Ejemplares similares

MELD-Na Alterations on the Liver Transplant Waiting List and Their Impact on Listing Outcome
por: Silberhumer, Gerd R., et al.
Publicado: (2023)

Locoregional Treatments for Bridging and Downstaging HCC to Liver Transplantation
por: Crocetti, Laura, et al.
Publicado: (2021)

Alpha‐fetoprotein‐adjusted‐to‐HCC‐size criteria are associated with favourable survival after liver transplantation for hepatocellular carcinoma
por: Meischl, Tobias, et al.
Publicado: (2021)

C-reactive protein is an independent predictor for hepatocellular carcinoma recurrence after liver transplantation
por: Meischl, Tobias, et al.
Publicado: (2019)

Optimal treatment for small HCC (<3 cm): Resection, liver transplantation, or locoregional therapy?
por: Wu, Xiao, et al.
Publicado: (2023)

A Multi-Centre Non-Interventional Study to Assess the Tolerability and Effectiveness of Extended-Release Tacrolimus (LCPT) in De Novo Liver Transplant Patients
por: Soliman, Thomas, et al.
Publicado: (2023)

Reirradiation for Locoregional Recurrent Breast Cancer
por: Fattahi, Sayeh, et al.
Publicado: (2020)

The von Willebrand Factor Facilitates Model for End‐Stage Liver Disease–Independent Risk Stratification on the Waiting List for Liver Transplantation
por: Györi, Georg P., et al.
Publicado: (2020)

Proton Reirradiation for Locoregionally Recurrent Breast Cancer
por: LaRiviere, Michael J., et al.
Publicado: (2021)

AFP Response to Locoregional Therapy Can Stratify the Risk of Tumor Recurrence in HCC Patients after Living Donor Liver Transplantation
por: Chen, I-Hsuan, et al.
Publicado: (2023)

Interventional Radiology Image-Guided Locoregional Therapies (LRTs) and Immunotherapy for the Treatment of HCC
por: Biondetti, Pierpaolo, et al.
Publicado: (2021)

Early-Stage HCC Percutaneous Locoregional Management: East versus West Perspectives
por: Iezzi, Roberto, et al.
Publicado: (2023)

HDR Brachytherapy and SBRT as Bridging Therapy to Liver Transplantation in HCC Patients: A Single-Center Experience
por: Walter, Franziska, et al.
Publicado: (2021)

Hepatocellular carcinoma progression during bridging before liver transplantation
por: Renner, P, et al.
Publicado: (2021)

Pathologic response after neoadjuvant chemotherapy predicts locoregional control in patients with triple negative breast cancer
por: Chen, Victor E., et al.
Publicado: (2017)

Adult Head and Neck Rhabdomyosarcoma: Management, Outcomes, and the Effect of Intensity Modulated Radiation Therapy on Locoregional Control
por: Hahn, Ezra, et al.
Publicado: (2022)

Impact of ultrasound examination shortly after kidney transplantation
por: Schwarz, Christoph, et al.
Publicado: (2017)

Standardized intraoperative application of an absorbable polysaccharide hemostatic powder to reduce the incidence of lymphocele after kidney transplantation – a prospective trial
por: Burghuber, Christopher K., et al.
Publicado: (2018)

Metastatic disease to the liver: Locoregional therapy strategies and outcomes
por: Zane, Kylie E, et al.
Publicado: (2021)

Patient-reported symptoms and interest in symptom monitoring in HCC treated with locoregional therapies: A qualitative study
por: Moon, Andrew M., et al.
Publicado: (2023)

Systematic review of treatment strategy for recurrent hepatocellular carcinoma: Salvage liver transplantation or curative locoregional therapy
por: Wang, Hong-Liang, et al.
Publicado: (2019)

Comparison of outcomes between SBRT, yttrium-90 radioembolization, transarterial chemoembolization, and radiofrequency ablation as bridge to transplant for hepatocellular carcinoma
por: Mohamed, Mostafa, et al.
Publicado: (2015)

Neoadjuvant programmed cell death 1 inhibitor before liver transplantation for HCC is not associated with increased graft loss
por: Wang, Tielong, et al.
Publicado: (2023)

Bridging locoregional treatment prior to liver transplantation for cirrhotic patients with hepatocellular carcinoma within the Milan criteria: a systematic review and meta-analysis
por: Kostakis, Ioannis D., et al.
Publicado: (2023)

Extended Postinterventional Tumor Necrosis—Implication for Outcome in Liver Transplant Patients with Advanced HCC
por: Kornberg, Arno, et al.
Publicado: (2013)

Blood Transfusions and Tumor Biopsy May Increase HCC Recurrence Rates after Liver Transplantation
por: Seehofer, Daniel, et al.
Publicado: (2017)

Continuing five or more locoregional therapies before living donor salvage liver transplantation for hepatocellular carcinoma is related to poor recurrence-free survival
por: Rhu, Jinsoo, et al.
Publicado: (2018)

Strategies for HCC target discovery
por: Molina-Sánchez, Pedro, et al.
Publicado: (2017)

Histological Correlation for Radiofrequency and Microwave Ablation in the Local Control of Hepatocellular Carcinoma (HCC) before Liver Transplantation: A Comprehensive Review
por: Habibollahi, Peiman, et al.
Publicado: (2020)

Favourable outcome of pathologic downstaging by locoregional treatment for hepatocellular carcinoma in liver transplantation
por: Kim, Deok Gie, et al.
Publicado: (2019)

Treating Relapsed/Refractory Acute Myeloid Leukemia with Chidamide, Fludarabine, Cytarabine and Granulocyte-Colony Stimulating Factor with Subsequent Bridging to Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation
por: Yao, Wen, et al.
Publicado: (2022)

Nonadherence to Multimodality Cancer Treatment Guidelines in the United States
por: Tchelebi, Leila T., et al.
Publicado: (2022)

Liver transplantation reverses hypergammaglobulinemia in patients with chronic hepatic failure
por: Lebherz-Eichinger, Diana, et al.
Publicado: (2015)

AFP ratio predicts HCC recurrence after liver transplantation
por: Koch, Christine, et al.
Publicado: (2020)

Routine Testing of Liver Function Before and After Elective Laparoscopic Cholecystectomy: Is It Necessary?
por: Ahmad, Nasir Zaheer
Publicado: (2011)

Postcolonial theory and Canada’s health care professions: bridging the gap
por: Wilmot, Stephen
Publicado: (2021)

Myocardial involvement in eosinophilic granulomatosis with polyangiitis: a multimodal approach
por: Persia-Paulino, Yvan R., et al.
Publicado: (2023)

The impact of COVID-19 on liver transplantation programs in Austria
por: Hartl, Lukas, et al.
Publicado: (2022)

New Challenges in the Management of Cholangiocarcinoma: The Role of Liver Transplantation, Locoregional Therapies, and Systemic Therapy
por: Mauro, Ezequiel, et al.
Publicado: (2023)

Therapeutic Strategies in HCC: Radiation Modalities
por: Gallicchio, R., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_o762uhh1p5l1fcs0noke3me7as